​

Carisma Therapeutics (CARM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Carisma Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$9.20M

Main Segment (Y)

Milestones

Carisma Therapeutics Revenue by Period

Carisma Therapeutics Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$14.92M51.71%
2022-12-31$9.83M-62.95%
2021-12-31$26.54M136.24%
2020-12-31$11.24M100.00%
2019-12-31-100.00%
2018-12-31--100.00%
2017-12-31$425.00K-98.58%
2016-12-31$29.98M2928.38%
2015-12-31$990.00K-55.86%
2014-12-31$2.24M68.14%
2013-12-31$1.33M100.00%
2012-12-31-100.00%
2011-12-31--

Carisma Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Carisma Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$9.20M170.74%
2024-03-31$3.40M-20.80%
2023-12-31$4.29M12.07%
2023-09-30$3.83M7.50%
2023-06-30$3.56M9.77%
2023-03-31$3.24M-13.08%
2022-12-31$3.73M44.72%
2022-09-30$2.58M-4.62%
2022-06-30$2.70M228.83%
2022-03-31$822.00K-95.89%
2021-12-31$20.00M100.00%
2021-09-30--100.00%
2021-06-30$2.23M-48.17%
2021-03-31$4.31M100.00%
2020-12-31--100.00%
2020-09-30$11.24M100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2017-03-31$425.00K-48.48%
2016-12-31$825.00K-97.12%
2016-09-30$28.65M10242.96%
2016-06-30$277.00K20.96%
2016-03-31$229.00K-59.47%
2015-12-31$565.00K743.28%
2015-09-30$67.00K-41.23%
2015-06-30$114.00K-53.28%
2015-03-31$244.00K-34.93%
2014-12-31$375.00K-30.43%
2014-09-30$539.00K-29.17%
2014-06-30$761.00K33.98%
2014-03-31$568.00K11.37%
2013-12-31$510.00K-18.01%
2013-09-30$622.00K207.92%
2013-06-30$202.00K100.00%
2013-03-31-100.00%
2012-12-31--

Carisma Therapeutics generated $9.20M in revenue during Q2 2024, up 170.74% compared to the previous quarter, and up 283.60% compared to the same period a year ago.

Carisma Therapeutics Revenue Breakdown

Carisma Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 20
Milestones$2.00M-
License Revenue-$11.24M

Carisma Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Milestones (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24
Milestones-$2.00M

Carisma Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ZVSAZyVersa Therapeutics--
CARMCarisma Therapeutics-$9.20M
IMMXImmix Biopharma--
ZURAZura Bio--
CNSPCNS Pharmaceuticals--
HEPAHepion Pharmaceuticals--
ENVBEnveric Biosciences--
PALIPalisade Bio--

CARM Revenue FAQ

What is Carisma Therapeutics’s yearly revenue?

Carisma Therapeutics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $14.92M, representing an increase of 51.71% compared to 2022. CARM's yearly revenue for 2022 was $9.83M, representing a decrease of -62.95% compared to 2021.

What is Carisma Therapeutics’s quarterly revenue?

Carisma Therapeutics's quarterly revenue for Q2 2024 was $9.2M, a 170.74% increase from the previous quarter (Q1 2024), and a 158.34% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.4M, a -20.80% decrease from the previous quarter (Q4 2023), and a 4.75% increase year-over-year (Q1 2023). CARM's quarterly revenue for Q4 2023 was $4.29M, a 12.07% increase from the previous quarter (Q3 2023), and a 14.96% increase year-over-year (Q4 2022).

What is Carisma Therapeutics’s revenue growth rate?

Carisma Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Carisma Therapeutics’s revenue streams?

Carisma Therapeutics's revenue streams in c 24 are Milestones

What is Carisma Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Carisma Therapeutics was Milestones. This segment made a revenue of $2M, representing 100.00% of the company's total revenue.